Content about Prostate cancer

September 27, 2010

Pfizer has halted a late-stage trial of a drug therapy in men with prostate cancer,...

NEW YORK Pfizer has halted a late-stage trial of a drug therapy in men with prostate cancer, the drug maker said.

Pfizer announced the discontinuation of “SUN 1120,” a phase-3 trial of Sutent (sunitinib malate) combined with the generic drug prednisone in men with advanced castration-resistant prostate cancer that had progressed despite chemotherapy. An analysis of data from the trial found that the men were not more likely to improve overall survival when taking the two drugs together than when they took prednisone alone.

July 20, 2010

Safeway raises more than $11 million for prostate cancer research

During what has become a familiar summer tradition that reaches millions of Safeway customers each...

June 16, 2010

FDA approves Jevtana

The Food and Drug Administration has approved a new treatment for advanced prostate cancer, the...

June 13, 2010

Diabetes may up cancer risk in women, study finds

Women with Type 2 diabetes may be more likely to develop certain cancers, a new...

June 2, 2010

Kimberly-Clark continues prostate cancer awareness campaign

The maker of Depend products is kicking off its “The Depend Campaign to End Prostate...

May 31, 2010

Safeway continues raising prostate cancer awareness with annual campaign

Safeway on Tuesday kicked off its annual prostate cancer fundraising and awareness campaign....

May 18, 2010

Amgen seeks regulatory approval for bone metastasis treatment

Amgen has submitted a regulatory approval application to the Food and Drug Administration for a...

May 2, 2010

BioSante to re-initiate prostate cancer vaccine program

Drug maker BioSante Pharmaceuticals has restarted a development program for a prostate cancer vaccine, the...

May 2, 2010

FDA: Certain prostate cancer drugs may cause other health problems

The Food and Drug Administration is investigating a possible link between drugs commonly used to...

March 30, 2010

FDA: Stalevo may increase male patients' risk of cancer

Data from a long-term clinical trial may indicate a possible cancer risk in men taking...

March 11, 2010

Late-stage clinical trial of Avastin fails to meet expectations, Genentech says

A late-stage clinical trial of a Genentech drug for men with late-stage prostate cancer has...

March 1, 2010

Impax Labs receives FDA approval for generic tamsulosin

The Food and Drug Administration has approved the first generic version of a drug for...

February 8, 2010

Amgen's prostate cancer drug more effective than competitor, study concludes

An investigational drug made by Amgen for treating prostate cancer that had spread to the...